Medical Science Liaisons Increasing, Lack Of Awareness By Doctors A Challenge
This article was originally published in PharmAsia News
The number of medical science liaisons, or MSLs, who provide information to key opinion leader doctors has increased from 11 people per company two years ago to 22 per company in Japan, according to a JaphMed survey.
You may also be interested in...
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.
Sandoz has appointed a new leader for its Japanese business following the acquisition of Aspen’s local operations, while Stada has brought in a former Sandoz and Pfizer executive to lead its Ciclum Farma unit in Portugal. Meanwhile, Julphar has a new CEO.